Company intelligence / Profile preview

Presymptom Health

Ownership: Private
Development stage: Other

Overview

Presymptom Health has developed a novel AI-powered diagnostic platform that uses host gene expression signatures to detect infections and predict sepsis up to three days earlier than current methods. Their lead product, InfectiClear®, demonstrated high accuracy (95–99% rule-out) in clinical studies across multiple NHS hospitals. The company has completed major clinical trials (PRECISION) with over nine UK sites involved, secured significant funding (£3M+), and aims for regulatory approval and UK launch by late/mid–2025.

Therapeutic areas: Infectious Diseases
Modalities: Diagnostic test (AI-based blood test)Device (diagnostic platform)Software (clinical decision-support software)
Industry: Molecular Diagnostics

Partnerships

Ploughshare Innovations (spin-out/licensing partner)Defence Science and Technology Laboratory (DSTL – original tech developer)NHS hospital network for trials

Beyond the preview

Go deeper on Presymptom Health.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Presymptom Health.

Explore the full profile